Advertisement
Screener

KERYX BIOPHARMACEUTICALS INC Research and Development Expense

KERYX BIOPHARMACEUTICALS INC Research and Development Expense

KERYX BIOPHARMACEUTICALS INC reported Research and Development Expense of $7.90 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2018-11-08

  • KERYX BIOPHARMACEUTICALS INC research and development expense for the quarter ending 2018-09-30 was $7.90M, a 14.87% decline year-over-year.
  • KERYX BIOPHARMACEUTICALS INC research and development expense for the quarter ending 2018-06-30 was $8.77M, a 2.64% decline year-over-year.
  • KERYX BIOPHARMACEUTICALS INC research and development expense for the quarter ending 2018-03-31 was $8.39M, a 24.01% increase year-over-year.
  • KERYX BIOPHARMACEUTICALS INC research and development expense for the quarter ending 2017-12-31 was $12.63M, a 104.17% increase year-over-year.
  • KERYX BIOPHARMACEUTICALS INC research and development expense for fiscal 2017 was $37.68M, a 27.71% increase from fiscal 2016.
  • KERYX BIOPHARMACEUTICALS INC research and development expense for fiscal 2016 was $29.50M, a 19.59% decline from fiscal 2015.
  • KERYX BIOPHARMACEUTICALS INC research and development expense for fiscal 2015 was $36.69M, a 28.75% decline from fiscal 2014.
  • KERYX BIOPHARMACEUTICALS INC research and development expense for fiscal 2014 was $51.50M, a 48.28% increase from fiscal 2013.
Period endResearch and Development Expense 3 monthResearch and Development Expense 6 monthResearch and Development Expense 9 monthResearch and Development Expense 12 month
2018-09-30$7.90M
10-Q · filed 2018-11-08
$16.67M
derived: sum of 2 quarters · filed 2018-11-08
$25.06M
10-Q · filed 2018-11-08
$37.69M
derived: sum of 4 quarters · filed 2018-11-08
2018-06-30$8.77M
10-Q · filed 2018-08-09
$17.16M
10-Q · filed 2018-08-09
$29.79M
derived: sum of 3 quarters · filed 2018-08-09
$39.06M
derived: sum of 4 quarters · filed 2018-11-08
2018-03-31$8.39M
10-Q · filed 2018-05-10
$21.02M
derived: sum of 2 quarters · filed 2018-05-10
$30.29M
derived: sum of 3 quarters · filed 2018-11-08
$39.30M
derived: sum of 4 quarters · filed 2018-11-08
2017-12-31$12.63M
10-K · filed 2018-02-21
$21.90M
derived: sum of 2 quarters · filed 2018-11-08
$30.91M
derived: sum of 3 quarters · filed 2018-11-08
$37.68M
10-K · filed 2018-02-21
2017-09-30$9.28M
10-Q · filed 2018-11-08
$18.29M
derived: sum of 2 quarters · filed 2018-11-08
$25.05M
10-Q · filed 2018-11-08
$31.24M
derived: sum of 4 quarters · filed 2018-11-08
2017-06-30$9.01M
10-Q · filed 2018-08-09
$15.78M
10-Q · filed 2018-08-09
$21.96M
derived: sum of 3 quarters · filed 2018-08-09
$30.64M
derived: sum of 4 quarters · filed 2018-08-09
2017-03-31$6.76M
10-Q · filed 2018-05-10
$12.95M
derived: sum of 2 quarters · filed 2018-05-10
$21.62M
derived: sum of 3 quarters · filed 2018-05-10
$28.65M
derived: sum of 4 quarters · filed 2018-05-10
2016-12-31$6.18M
10-K · filed 2018-02-21
$14.86M
derived: sum of 2 quarters · filed 2018-02-21
$21.89M
derived: sum of 3 quarters · filed 2018-02-21
$29.50M
10-K · filed 2018-02-21
2016-09-30$8.67M
10-K · filed 2018-02-21
$15.70M
derived: sum of 2 quarters · filed 2018-02-21
$23.32M
10-Q · filed 2017-11-07
$31.31M
derived: sum of 4 quarters · filed 2018-02-21
2016-06-30$7.03M
10-K · filed 2018-02-21
$14.64M
10-Q · filed 2017-07-27
$22.64M
derived: sum of 3 quarters · filed 2018-02-21
$33.78M
derived: sum of 4 quarters · filed 2018-02-21
2016-03-31$7.62M
10-K · filed 2018-02-21
$15.61M
derived: sum of 2 quarters · filed 2018-02-21
$26.76M
derived: sum of 3 quarters · filed 2018-02-21
$34.72M
derived: sum of 4 quarters · filed 2018-02-21
2015-12-31$7.99M
10-K · filed 2017-03-01
$19.14M
derived: sum of 2 quarters · filed 2017-03-01
$27.10M
derived: sum of 3 quarters · filed 2017-03-01
$36.69M
10-K · filed 2018-02-21
2015-09-30$11.15M
10-K · filed 2017-03-01
$19.11M
derived: sum of 2 quarters · filed 2017-03-01
$28.70M
10-Q · filed 2016-11-09
$34.52M
derived: sum of 4 quarters · filed 2017-03-01
2015-06-30$7.96M
10-K · filed 2017-03-01
$17.55M
10-Q · filed 2016-08-05
$23.37M
derived: sum of 3 quarters · filed 2017-03-01
$42.42M
derived: sum of 4 quarters · filed 2017-03-01
2015-03-31$9.59M
10-K · filed 2017-03-01
$15.41M
derived: sum of 2 quarters · filed 2017-03-01
$34.46M
derived: sum of 3 quarters · filed 2017-03-01
$44.73M
derived: sum of 4 quarters · filed 2017-03-01
2014-12-31$5.82M
10-K · filed 2016-02-26
$24.87M
derived: sum of 2 quarters · filed 2016-02-26
$35.14M
derived: sum of 3 quarters · filed 2016-02-26
$51.50M
10-K · filed 2017-03-01
2014-09-30$19.05M
10-K · filed 2016-02-26
$29.33M
derived: sum of 2 quarters · filed 2016-02-26
$45.69M
10-Q · filed 2015-10-29
$56.14M
derived: sum of 4 quarters · filed 2016-02-26
2014-06-30$10.28M
10-K · filed 2016-02-26
$26.63M
10-Q · filed 2015-08-06
$37.09M
derived: sum of 3 quarters · filed 2016-02-26
$47.76M
derived: sum of 4 quarters · filed 2016-02-26
2014-03-31$16.36M
10-K · filed 2016-02-26
$26.82M
derived: sum of 2 quarters · filed 2016-02-26
$37.49M
derived: sum of 3 quarters · filed 2016-02-26
$44.66M
derived: sum of 4 quarters · filed 2016-02-26
2013-12-31$10.46M
10-K · filed 2015-02-27
$21.13M
derived: sum of 2 quarters · filed 2015-02-27
$28.30M
derived: sum of 3 quarters · filed 2015-02-27
$34.73M
10-K · filed 2016-02-26
2013-09-30$10.67M
10-K · filed 2015-02-27
$17.85M
derived: sum of 2 quarters · filed 2015-02-27
$24.28M
10-Q · filed 2014-11-06
$29.18M
derived: sum of 4 quarters · filed 2015-02-27
2013-06-30$7.18M
10-K · filed 2015-02-27
$13.61M
10-Q · filed 2014-08-07
$18.51M
derived: sum of 3 quarters · filed 2015-02-27
$22.44M
derived: sum of 4 quarters · filed 2015-02-27
2013-03-31$6.43M
10-K · filed 2015-02-27
$11.33M
derived: sum of 2 quarters · filed 2015-02-27
$15.26M
derived: sum of 3 quarters · filed 2015-02-27
$19.06M
derived: sum of 4 quarters · filed 2015-02-27
2012-12-31$4.90M
10-K · filed 2014-03-13
$8.83M
derived: sum of 2 quarters · filed 2014-03-13
$12.63M
derived: sum of 3 quarters · filed 2014-03-13
$20.03M
10-K · filed 2015-02-27
2012-09-30$3.93M
10-K · filed 2014-03-13
$7.73M
derived: sum of 2 quarters · filed 2014-03-13
$15.13M
10-Q · filed 2013-11-04
$21.99M
derived: sum of 4 quarters · filed 2014-03-13
2012-06-30$3.80M
10-K · filed 2014-03-13
$11.20M
10-Q · filed 2013-08-02
$18.06M
derived: sum of 3 quarters · filed 2014-03-13
$26.83M
derived: sum of 4 quarters · filed 2014-03-13
2012-03-31$7.40M
10-K · filed 2014-03-13
$14.26M
derived: sum of 2 quarters · filed 2014-03-13
$23.04M
derived: sum of 3 quarters · filed 2014-03-13
$29.54M
derived: sum of 4 quarters · filed 2014-03-13
2011-12-31$6.86M
10-K · filed 2013-03-12
$15.63M
derived: sum of 2 quarters · filed 2013-03-12
$22.14M
derived: sum of 3 quarters · filed 2013-03-12
$27.01M
10-K · filed 2014-03-13
2011-09-30$8.77M
10-K · filed 2013-03-12
$15.27M
derived: sum of 2 quarters · filed 2013-03-12
$20.15M
10-Q · filed 2012-11-08
$24.53M
derived: sum of 4 quarters · filed 2013-03-12
2011-06-30$6.50M
10-K · filed 2013-03-12
$11.38M
10-Q · filed 2012-08-08
$15.76M
derived: sum of 3 quarters · filed 2013-03-12
$19.98M
derived: sum of 4 quarters · filed 2013-03-12
2011-03-31$4.88M
10-K · filed 2013-03-12
$9.26M
derived: sum of 2 quarters · filed 2013-03-12
$13.48M
derived: sum of 3 quarters · filed 2013-03-12
$17.05M
derived: sum of 4 quarters · filed 2013-03-12
2010-12-31$4.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12
$8.61M
derived: sum of 2 quarters · filed 2013-03-12
$12.17M
derived: sum of 3 quarters · filed 2013-03-12
$14.96M
10-K · filed 2013-03-12
2010-09-30$4.22M
10-Q · filed 2011-11-04
$7.79M
derived: sum of 2 quarters · filed 2011-11-04
$10.58M
10-Q · filed 2011-11-04
2010-06-30$3.56M
10-Q · filed 2011-08-08
$6.36M
10-Q · filed 2011-08-08
2009-12-31$8.61M
10-K · filed 2012-03-02